PepGen Company Top Insiders
| PEPG Stock | USD 6.51 0.09 1.40% |
PepGen employs about 57 people. The company is managed by 20 executives with a total tenure of roughly 133 years, averaging almost 6.0 years of service per executive, having 2.85 employees per reported executive. Examination of PepGen's management performance can provide insight into the company performance.
PepGen Management Team Effectiveness
The company has return on total asset (ROA) of (0.3409) % which means that it has lost $0.3409 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.6225) %, meaning that it created substantial loss on money invested by shareholders. PepGen's management efficiency ratios could be used to measure how well PepGen manages its routine affairs as well as how well it operates its assets and liabilities.PepGen owns a total of 68.75 Million outstanding shares. The majority of PepGen outstanding shares are owned by third-party entities. These institutional holders are usually referred to as non-private investors looking to secure positions in PepGen to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in PepGen. Please pay attention to any change in the institutional holdings of PepGen as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in stocks such as PepGen in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of PepGen, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
PepGen Workforce Comparison
PepGen is regarded fifth in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 857. PepGen holds roughly 57.0 in number of employees claiming about 7% of equities under Health Care industry.
PepGen Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific PepGen insiders, such as employees or executives, is commonly permitted as long as it does not rely on PepGen's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, PepGen insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Mellion Michelle L over two months ago Disposition of 7571 shares by Mellion Michelle L of PepGen at 10.21 subject to Rule 16b-3 | ||
Resnick Joshua over six months ago Acquisition by Resnick Joshua of 16000 shares of PepGen at 1.51 subject to Rule 16b-3 | ||
Streck Paul over six months ago Acquisition by Streck Paul of 8375 shares of PepGen at 1.241 subject to Rule 16b-3 | ||
James McArthur over six months ago Acquisition by James McArthur of 41500 shares of PepGen at 1.15 subject to Rule 16b-3 | ||
Wyman Lisa over six months ago Insider Trading | ||
James McArthur over six months ago Disposition of 2381 shares by James McArthur of PepGen at 2.71 subject to Rule 16b-3 | ||
Ra Capital Management, L.p. over six months ago Acquisition by Ra Capital Management, L.p. of 2557593 shares of PepGen at 10.64 subject to Rule 16b-3 | ||
James McArthur over six months ago Acquisition by James McArthur of 60719 shares of PepGen subject to Rule 16b-3 |
PepGen Notable Stakeholders
A PepGen stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as PepGen often face trade-offs trying to please all of them. PepGen's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting PepGen's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| James McArthur | CEO and President | Profile | |
| Caroline Godfrey | Founder Member | Profile | |
| MBA CFA | Senior Communications | Profile | |
| JD Esq | Chief Officer | Profile | |
| Afsaneh Mohebbi | Senior Management | Profile | |
| Michelle MD | Senior Development | Profile | |
| David CFA | Senior Communications | Profile | |
| Jaya Goyal | Executive Development | Profile | |
| MD MBA | Executive Development | Profile | |
| Kasra Kasraian | Chief Officer | Profile | |
| Hayley Parker | Senior Affairs | Profile | |
| Sonia DPHIL | VP Operations | Profile | |
| Michael Gait | Founder Member | Profile | |
| Jennifer Cormier | VP Operations | Profile | |
| Mary DeLena | General Secretary | Profile | |
| Mary JD | General Secretary | Profile | |
| Kyle Breidenstine | VP Controller | Profile | |
| Emiko Bryant | Senior Administration | Profile | |
| Noel MBA | Chief Officer | Profile | |
| Niels Svenstrup | Manufacturing Chemistry | Profile |
About PepGen Management Performance
The success or failure of an entity such as PepGen often depends on how effective the management is. PepGen management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of PepGen management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the PepGen management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
PepGen Inc., a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases. The company was founded in 2018 and is headquartered in Cambridge, Massachusetts. Pepgen operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 36 people.
PepGen Workforce Analysis
Traditionally, organizations such as PepGen use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare PepGen within its industry.PepGen Manpower Efficiency
Return on PepGen Manpower
| Revenue Per Employee | 0.0 | |
| Revenue Per Executive | 0.0 | |
| Net Loss Per Employee | 1.6M | |
| Net Loss Per Executive | 4.5M | |
| Working Capital Per Employee | 1.9M | |
| Working Capital Per Executive | 5.4M |
Complementary Tools for PepGen Stock analysis
When running PepGen's price analysis, check to measure PepGen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PepGen is operating at the current time. Most of PepGen's value examination focuses on studying past and present price action to predict the probability of PepGen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PepGen's price. Additionally, you may evaluate how the addition of PepGen to your portfolios can decrease your overall portfolio volatility.
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |